HiberCell and Strasbourg Institute for Precision Medicine publish machine learning data and approach on causal biology of severe COVID-19 October 28, 2021 Categories: Health Care Tags: HiberCell
HiberCell Receives fast track designation from FDA for first-in-human studies of PERK Inhibitor HC-5404-FU September 10, 2021 Categories: Health Care Tags: HiberCell
HiberCell closes $67.4 million Series B financing May 19, 2021 Categories: Health Care Tags: HiberCell
